FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention provides pharmaceutical compositions, which include an effective quantity of ceftaroline fosamile or its pharmaceutically acceptable salt and an antibacterial agent or its pharmaceutically acceptable salt. The antibacterial agent is selected from a group, consisting of meropenem, piperacillin plus tazobactam, amikacin and astreonam.
EFFECT: compositions by the invention produce a synergistic effect on bacteria strains, are used in treatment of bacterial infections.
7 cl, 2 dwg, 17 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOLUBLE DOSAGE FORMS CONTAINING CEPHEM DERIVATIVES APPLICABLE FOR PARENTERAL ADMINISTRATION | 2008 |
|
RU2537237C2 |
| COMBINED THERAPEUTIC AGENTS CONTAINING OXAZOLIDINONES-QUINOLONES INTENDED FOR TREATMENT OF BACTERIAL INFECTIONS | 2014 |
|
RU2675847C2 |
| COMBINATION THERAPY FOR TREATING NOSOCOMIAL PNEUMONIA | 2014 |
|
RU2684112C2 |
| COMPOSITION COMPRISING AN ANTIBIOTIC AND A DISPERSANT OR AN ANTI-ADHESIVE AGENT | 2011 |
|
RU2607660C2 |
| COMPOSITION COMPRISING AN ANTIBIOTIC AND A DISPERSING AGENT OR AN ANTI-ADHESIVE AGENT | 2011 |
|
RU2739249C2 |
| PIPERACILLIN AND TAZOBACTAM-CONTAINING COMPOSITIONS USED FOR INJECTION | 2004 |
|
RU2322980C2 |
| ANTIBACTERIAL COMPOUNDS | 2009 |
|
RU2525915C2 |
| COMPOUNDS FOR TREATING CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES | 2011 |
|
RU2575477C2 |
| NOVEL SINGLE-UNIT FORMULATIONS OF CARBAPENEM AND AMINOGLYCOSIDE | 2009 |
|
RU2521391C2 |
| USING LEVOFLOXACIN IN AEROSOL FORM FOR TREATING MUCOVISCIDOSIS | 2010 |
|
RU2563809C2 |
